2025.12.12
Dimethyl sulfoxide (DMSO), a longstanding cryoprotective agent in cell freezing media, is plagued by inherent toxicity. Even at low concentrations (0.04‰), it inhibits cell growth; at the common 10% concentration, inhibition reaches nearly 100%. Clinically, DMSO poses severe risks (flushing, arrhythmia, renal failure), while post-thaw washing to reduce residuals causes significant target cell loss (e.g., 48.51% viable CD34+ cell loss), creating a dilemma between toxicity mitigation and cell preservation.
Driven by advances in cell and gene therapy (CGT) and regenerative medicine, demand for DMSO-free solutions has surged. To address this, we officially launch Cell Freezing Media - DMSO Free, a cutting-edge, non-toxic solution for research and clinical translation.
Core advantages:
1) Complete DMSO elimination, avoiding toxicity and clinical risks;
2) Optimized formula ensures up to 90% post-thaw viability, maintains cell function and ISCT-compliant MSC markers;
3) Validated for hPBMCs, MSCs, and other cell types;
4) Ready-to-use for convenience;
5) GMP/ISO-compliant production with strict batch consistency and comprehensive CoA.
This launch underscores our commitment to safer cell preservation. Whether for basic research, biobanking, or clinical therapy, our DMSO-free media accelerates your work with reliable performance and peace of mind.
For inquiries, free samples, or technical docs, please contact Info@milecell-bio.com.
